[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Astellas Pharma Inc.
Astellas Pharma's XTANDI shows significant reduction in death risk for advanced prostate cancer, driving positive sentiment. Speculation around a potential TSHA buyout also influences market interest.
About Astellas Pharma Inc.
Astellas Pharma Inc. is a global pharmaceutical company.
Insights
- Astellas Pharma Inc. Price hit a 52-Week high of $XXXXX for the hour
- Astellas Pharma Inc. Price hit an all time of $XXXXX for the hour
Price: $
Price 24-Hour Time-Series Raw Data
The price hit a 52-week high, supported by positive sentiment around XTANDI's clinical trial results and potential TSHA buyout, suggesting expected positive news is driving the price up.
1-Year High: $XXXXX on 2025-12-10
1-Year Low: $XXXXX on 2025-04-09
AltRank: XXX
AltRank 24-Hour Time-Series Raw Data
Astellas Pharma Inc. is currently AltRank #327 based on combined combined social and market metrics
Daily Average: XXX
1-Year High: XXXXX on 2025-03-10
1-Year Low: XXX on 2025-12-12
Galaxy Score: XX
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1-Year High: XX on 2025-07-29
1-Year Low: XX on 2024-12-14
Engagements: XXXXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
X Week: XXXXX -XX%
X Month: XXXXXX -XX%
X Months: XXXXXXX -XX%
X Year: XXXXXXXXX -X%
1-Year High: XXXXXXX on 2025-03-28
1-Year Low: XX on 2025-01-27
Engagements by network (24h): Reddit: XXX TikTok: XX X: XXX YouTube: XX
Mentions: XXX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XX
X Week: XXX -XXXX%
X Month: XXX -XX%
X Months: XXXXX +13%
X Year: XXXXX +189%
1-Year High: XXX on 2025-07-18
1-Year Low: X on 2025-02-03
Mentions by network (24h): Reddit: XXX TikTok: X X: XXX YouTube: XX
Creators: XX (24h)
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Astellas Pharma Inc. in the last XX hours which is up XX% from XX in the previous XX hours
Daily Average: XX
X Week: XXX -XXXX%
X Month: XXX -XX%
X Months: XXX +8.80%
X Year: XXXXX +170%
1-Year High: XXX on 2025-07-18
1-Year Low: X on 2025-02-03
The most influential creators that mention Astellas Pharma Inc. in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @AstellasUS | X | XXXXXX | XX | XXX |
| @H2AK119ub | X | XXXXXX | X | XX |
| @BiotechAnalysst | X | XXXXX | X | XX |
| @OzmosiHealth | X | XXXXX | X | XX |
| @ABNewswire | X | XXXXX | X | XX |
| @wolframite | X | XXXXXX | X | XX |
| @astellaspharmaglobal | X | XXXXX | X | XX |
| @DryBoysenberry596 | X | XXXXXX | X | XX |
| @MensHlthNetwork | X | XXXXXX | X | XX |
| @PillsinaPod | XX | X | X | X |
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% +3%
X Month: XX% -X%
X Months: XX% -XX%
X Year: XX% +7%
1-Year High: XXX% on 2024-12-14
1-Year Low: XX% on 2025-01-28
Most Supportive Themes:
- XTANDI's Positive Clinical Data: (60%) Positive clinical data for XTANDI showing a significant reduction in death risk for advanced prostate cancer patients.
- Potential TSHA Buyout: (20%) Speculation and discussion surrounding a potential acquisition of TSHA, which could impact Astellas's strategic positioning.
- STAT6 Inhibitor Programs: (10%) Advancements and discussions related to Astellas's STAT6 Inhibitor Programs, indicating progress in their research and development pipeline.
Most Critical Themes:
- Mental Health and Diagnostic Challenges: (1%) Concerns and discussions regarding mental health issues and the complexities associated with cancer diagnosis.
Market Cap: $undefined
Market Cap 24-Hour Time-Series Raw Data
Current Value: $undefined
Daily Average: $XXXXXXXXXXXXXXXXX
1-Year High: $XXXXXXXXXXXXXXXXX on 2024-12-13
1-Year Low: $XXXXXXXXXXXXXXXXX on 2025-02-07
Top Astellas Pharma Inc. Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$ALPMY Astellas Pharma presented P2 Gastrointestinal Cancer results on 2025-01-08 for Zolbetuximab More Info:"
X Link @OzmosiHealth 2025-12-11T18:33Z 3016 followers, XXX engagements
"Ovarian Cancer Pipeline 2025: Key Companies MOA ROA and Clinical Trials Evaluation by DelveInsight Pfizer Daiichi Sankyo Astellas Pharma Jiangsu HengRui Boehringer Ingelheim #Business #HealthMedicine #MarketingSales #PharmaceuticalsBiotech"
X Link @ABNewswire 2025-12-11T15:56Z 1656 followers, XX engagements
"Ovarian Cancer Pipeline 2025: Key Companies MOA ROA and Clinical Trials Evaluation by DelveInsight Pfizer Daiichi Sankyo Astellas Pharma Jiangsu HengRui Boehringer Ingelheim Impact Therap"
X Link @newjerseyheadli 2025-12-11T14:33Z XXX followers, XX engagements
"Just announced: Astellas will present new data in #PancreaticCancer and #GastricCancer at ASCO #GI26. Learn more about our presentations and biomarker-driven approach to cancer innovation: For U.S. audiences only"
X Link @AstellasUS 2025-12-11T01:00Z 51.1K followers, XXX engagements